We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-19.38%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$398M
AUM Growth
-$344M
Cap. Flow
-$248M
Cap. Flow %
-62.23%
Top 10 Hldgs %
44.07%
Holding
188
New
36
Increased
27
Reduced
23
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 30.17%
2 Healthcare 20.63%
3 Industrials 11.87%
4 Utilities 10.14%
5 Consumer Staples 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUN icon
1
Sunrun
RUN
$2.3B
$24.9M 6.27%
2,290,000
+270,000
+13% +$3.41M
FTAI icon
2
FTAI Aviation
FTAI
$21.8B
$21.5M 5.4%
1,756,868
+406,822
+30% +$5.67M
AY
3
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$20.8M 5.23%
1,062,516
+236,320
+29% +$4.68M
STKL
4
DELISTED
SunOpta
STKL
$19.8M 4.97%
5,112,430
+698,201
+16% +$3.98M
EVA
5
DELISTED
Enviva Inc.
EVA
$16.3M 4.09%
586,703
+58,391
+11% +$1.73M
ELV icon
6
Elevance Health
ELV
$83.7B
$16M 4.03%
61,000
-21,500
-26% -$5.91M
MSFT icon
7
Microsoft
MSFT
$2.92T
$15M 3.77%
147,000
-72,000
-33% -$7.71M
ADBE icon
8
Adobe
ADBE
$99B
$14.1M 3.55%
62,500
+28,000
+81% +$6.76M
JAZZ icon
9
Jazz Pharmaceuticals
JAZZ
$16.1B
$13.6M 3.43%
110,000
-7,500
-6% -$1.11M
MBII
10
DELISTED
Marrone Bio Innovations, Inc.
MBII
$13.2M 3.32%
10,323,247
CVS icon
11
CVS Health
CVS
$140B
$12.8M 3.21%
+195,000
New +$14.6M
PTE
12
DELISTED
PolarityTE, Inc. Common Stock
PTE
$12.2M 3.08%
36,312
+17,052
+89% +$6.17M
UPLD icon
13
Upland Software
UPLD
$14.4M
$11.1M 2.8%
41,000
+5,000
+14% +$1.5M
WAAS
14
DELISTED
AquaVenture Holdings Limited
WAAS
$10.9M 2.74%
580,291
+35,039
+6% +$633K
CELG
15
DELISTED
Celgene Corp
CELG
$9.93M 2.5%
155,000
+146,000
+1,622% +$10.8M
XLNX
16
DELISTED
Xilinx Inc
XLNX
$9.54M 2.4%
112,000
-46,500
-29% -$3.89M
CTLP
17
DELISTED
Cantaloupe
CTLP
$9.34M 2.35%
2,400,000
+1,475,000
+159% +$7.74M
XBI icon
18
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$8.97M 2.25%
+125,000
New +$10.1M
ZEN
19
DELISTED
ZENDESK INC
ZEN
$8.9M 2.24%
152,500
+148,500
+3,713% +$8.55M
NOW icon
20
ServiceNow
NOW
$114B
$7.65M 1.92%
215,000
+190,000
+760% +$6.74M
GE icon
21
CALL
GE Aerospace
GE
$377B
$7.57M 1.9%
208,662
+187,796
+900% +$8.48M
AQUA
22
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$7.55M 1.9%
+787,500
New +$9.08M
TLND
23
DELISTED
Talend S.A. American Depositary Shares
TLND
$7.5M 1.88%
+202,150
New +$9.74M
FND icon
24
Floor & Decor
FND
$6.14B
$7.25M 1.82%
+280,000
New +$8.17M
CWEN.A
25
DELISTED
Clearway Energy Class A
CWEN.A
$7.16M 1.8%
423,048
+5,000
+1% +$92.3K

Similar funds

Ardsley Advisory Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ardsley Advisory Partners held 188 positions worth $398M, down 46% from $742M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ardsley Advisory Partners withdrew a net $248M in Q4 2018, closing 84 positions and reducing 23 holdings. Its most notable exit was Marathon Petroleum, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in CVS Health worth $12.8M.

  • Ardsley Advisory Partners's largest Q4 2018 buy was CVS Health: 195,000 shares worth $12.8M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q4 2018, an estimated $10.8M increase.
  • Ardsley Advisory Partners's biggest Q4 2018 reduction was Progenics Pharmaceuticals Inc, cutting an estimated $7.73M.
  • Ardsley Advisory Partners fully exited Marathon Petroleum in Q4 2018, selling an estimated $27M.
  • Ardsley Advisory Partners's ten largest holdings make up 44% of its $398M portfolio in Q4 2018.
  • Ardsley Advisory Partners opened 36 new positions and closed 84 in Q4 2018.
  • Ardsley Advisory Partners's portfolio value fell 46% quarter-over-quarter to $398M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.